Peritoneal carcinomatosis. Surgical treatment, including hyperthermal intraperitoneal chemotherapy

Glockzin, G. and Ghall, N. and Lang, S. A. and Agha, A. and Schlitt, H. J. and Piso, P. (2007) Peritoneal carcinomatosis. Surgical treatment, including hyperthermal intraperitoneal chemotherapy. CHIRURG, 78 (12). 1100-+. ISSN 0009-4722,

Full text not available from this repository. (Request a copy)

Abstract

Colorectal cancer is a common malignant disease with increasing incidence and a significant cause of death in cancer patients. More than 10% of patients with colorectal cancer show peritoneal carcinomatosis at initial diagnosis. Moreover, peritoneal metastasis is a common sign of recurrence. Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) are a new treatment strategy for highly selected patients with peritoneal carcinomatosis. Numerous studies show prolonged survival after CRS and HIPEC with acceptable morbidity and mortality rates. Accurate preoperative diagnostics and patient selection play a pivotal role in postoperative patient outcome. This promising treatment strategy is discussed regarding surgical technique, intraperitoneal chemotherapy, and patient outcome.

Item Type: Article
Uncontrolled Keywords: COMPLETE CYTOREDUCTIVE SURGERY; COLORECTAL-CANCER; MORTALITY ANALYSIS; RANDOMIZED-TRIAL; MORBIDITY; COLON; CHEMOHYPERTHERMIA; OXALIPLATIN; MANAGEMENT; ORIGIN; colorectal cancer; cytoreductive surgery; hyperthermic intraperitoneal chemotherapy; peritoneal carcinomatosis
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Chirurgie
Depositing User: Dr. Gernot Deinzer
Date Deposited: 25 Nov 2020 08:01
Last Modified: 25 Nov 2020 08:01
URI: https://pred.uni-regensburg.de/id/eprint/31825

Actions (login required)

View Item View Item